Shire plc, the global specialty biopharmaceutical company, announced that the United States District Court for the District of Columbia, following extensive briefing by the parties and an oral hearing, has upheld the decision of the US Food and Drug Administration (US FDA) to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate—currently marketed by Shire US Inc ...
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Chemical Entity, Company Announced That, District Court For The District Of Columbia, District Of Columbia, Fda, Food And Drug, Food And Drug Administration, Market Exclusivity, Plc, Shire Us Inc, States District Court, United States District, United States District Court, Us Food And Drug Administration
Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate ...
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Chemical Entity, Columbia Court, District Court For The District Of Columbia, District Of Columbia, Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Lse, Market Exclusivity, Nasdaq, Plc, Shp, States District Court, United States District, United States District Court
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Attention Deficit Disorder, Aviva, Bloomberg Uk, Columbia, Exclusivity, Food And Drug, Food And Drug Administration, Raquo, Shire, Us Food And Drug Administration, Vyvanse, Wpp
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by ...
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Chemical Entity, Columbia Court, District Court For The District Of Columbia, District Of Columbia, Exclusivity, Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Plc, Shire, States District Court, United States District, United States District Court
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Attention Deficit Disorder, Bloomberg Uk, Columbia, Exclusivity, Food And Drug, Food And Drug Administration, Raquo, Shire, Us Food And Drug Administration, Vyvanse, Wpp
